Merck (NYSE: MRK) announced it will acquire Terns Pharmaceuticals Inc. (NASDAQ: TERN) for $53.00 per share in cash, representing an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE